FDA Wants Wockhardt Management Audited in Quality Data Probe

Washington Drug Letter
The FDA wants Wockhardt to investigate whether management was involved in quality data manipulation at its Chikalthana, India, facility before the agency will lift an import ban it slapped on the plant Nov. 26.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00